PATENT CLAIM ANALYSIS

Application Number: 16075415
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "601000"]

Abstract:
Provided is a compound having α4 integrin inhibitory action. The compound is a sulfonamide derivative represented by the following formula (I), or pharmaceutically acceptable salt thereof: where R 1  to R 5 , e to h, D, and B represent those as described in the specification.

Claim (Index 26):
A therapeutic agent or prophylactic agent for an inflammatory disease in which an \u03b14\u03b27 integrin-dependent adhesion process is involved in a disease state, the agent comprising a sulfonamide derivative or pharmaceutically acceptable salt thereof according to  claim 1 .

Metadata:
- Claim Count in Document: 48.0
- Percentile: 96.0
- Lexical Diversity: 1.22727
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15142858', '14397078', '10594369', '09881913', '13709798']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7706242538806317
- 35 USC 102 Novelty (BERT): 0.5608504020007321
- Combined Prediction Score: 0.7496468686926417
- Mean Citation Score: 384.464128
- Max Citation Score: 429.26108
- Similarity Product: 354.6652305610943

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test